A Clinical Trial of Early Ventilation in Amyotrophic Lateral Sclerosis (EVENT ALS) | MicrobiomeTrials← Back to trialsNCT07071935
A Clinical Trial of Early Ventilation in Amyotrophic Lateral Sclerosis (EVENT ALS)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-06-11Est. Completion: 2029-05
Enrollment target: 48 participants Locations- Penn State Hershey ALS Clinic, Hershey, Pennsylvania, United States
- Penn Comprehensive ALS Center at Pennsylvania Hospital, Philadelphia, Pennsylvania, United States
- Thomas Jefferson University Weinberg ALS Center, Philadelphi, Pennsylvania, United States
Other microbiome trials you might be interested in
Amyotrophic Lateral Sclerosis
The purpose of this 2-part study is to assess the safety and efficacy of CORT113176 (dazucorilant) in patients with Amyo…
Phoenix, United StatesEst. completion Oct 2026
Amyotrophic Lateral Sclerosis
The median survival of patients with amyotrophic lateral sclerosis (ALS) is 3 to 5 years and mortality is mainly related…
Montpellier, FranceCompleted Oct 21, 2025